Home › Free Stock Grades › ANIK
Anika Therapeutics, Inc. (ANIK) Stock Grade
ANIK · Healthcare
C
Market Cap
$276.8M
P/E Ratio
—
Revenue Growth (YoY)
-5.9%
Net Margin
-9.6%
Return on Equity
—
Dividend Yield
None
About Anika Therapeutics, Inc.'s fundamentals
Anika Therapeutics is a specialty medical company with a market capitalization of $276.8 million that reported a net loss in its latest annual statement, with a net margin of -9.6%. Revenue declined 5.9% year-over-year, indicating a contracting top line during the period. Despite the accounting losses, the company generated positive free cash flow, suggesting operational cash generation independent of reported earnings. The company does not pay a dividend to shareholders.